Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lucia E.A. de Wit"'
Autor:
Brenda C. M. de Winter, Dennis A. Hesselink, Yi Li, Ron H.N. van Schaik, Lin Yang, Birgit C. P. Koch, Marith I. Francke, Teun van Gelder, Carla C. Baan, Lucia E.A. de Wit
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 87(4), 1918-1929. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology, 87(4), 1918-1929. Wiley-Blackwell Publishing Ltd
Aims: Tacrolimus is a critical dose drug and to avoid under- and overexposure, therapeutic drug monitoring is standard practice. However, rejection and drug-related toxicity occur despite whole-blood tacrolimus pre-dose concentrations ([Tac]blood) be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1fdadff58ebb82239059c1fa1083171
http://europepmc.org/articles/PMC8056738
http://europepmc.org/articles/PMC8056738
Autor:
Soma Bahmany, Lucia E.A. de Wit, Birgit C. P. Koch, Teun van Gelder, Brenda C. M. de Winter, Nauras Shuker, Bart C. H. van der Nagel, Carla C. Baan, Dennis A. Hesselink
Publikováno v:
Biomedical Chromatography
Biomedical Chromatography, 33(1):e4416. John Wiley & Sons Ltd.
Biomedical Chromatography, 33(1):e4416. John Wiley & Sons Ltd.
After solid organ transplantation, tacrolimus is given to prevent rejection. Therapeutic drug monitoring is used to reach target concentrations of tacrolimus in whole blood. Because the site of action of tacrolimus is the lymphocyte, and tacrolimus b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff00a7d7b18ee00de80d1a9653a391ab
http://europepmc.org/articles/PMC6587946
http://europepmc.org/articles/PMC6587946